- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
Results
104
0 new
Companys with strong funding and high growth potential
104 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BOVN.F | SEK 4.70 | 0% | n/a | SEK 2.7b | SEK 12.58 | PS9.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
0RV2 | SEK 165.90 | -3.0% | -40.2% | SEK 14.4b | SEK 295.23 | PS48.2x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | Pharmaceuticals & Biotech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €524.58 | -2.2% | 7.9% | €28.5b | €562.17 | PS19.2x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
IVVD | US$1.04 | -14.8% | -41.2% | US$117.1m | US$8.65 | PS54.9x | E70.4% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
BIOABS | SEK 173.90 | 0% | -37.8% | SEK 14.6b | SEK 306.27 | PS48.7x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
ARGN.F | €525.60 | 0% | n/a | €29.0b | €553.40 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARDX | US$6.36 | 6.2% | 57.4% | US$1.4b | US$11.28 | PS7.1x | E66.3% | n/a | Pharmaceuticals & Biotech | ||
ARGXB | €481.80 | 0% | 5.3% | €29.0b | €507.28 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
0QW0 | €487.57 | 2.5% | 7.8% | €29.0b | €513.36 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
BRCT.F | SEK 16.04 | -5.0% | -37.1% | SEK 14.4b | SEK 28.25 | PS48.7x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
AKES.F | HK$8.40 | -0.9% | n/a | HK$55.4b | HK$8.64 | PS26.6x | E54.5% | n/a | Pharmaceuticals & Biotech | ||
0HOJ | US$88.10 | -4.4% | 75.9% | US$5.5b | US$125.98 | PS15.6x | E67.4% | n/a | Pharmaceuticals & Biotech | ||
BPMC | US$89.06 | -2.1% | 74.4% | US$5.5b | US$127.35 | PS15.6x | E67.4% | n/a | Pharmaceuticals & Biotech | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
URGN | US$12.86 | -1.8% | -14.8% | US$550.0m | US$43.10 | PS6.4x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
CSPH.F | HK$0.19 | 0% | -35.1% | HK$1.9b | n/a | PS3.7x | E69.5% | n/a | Pharmaceuticals & Biotech | ||
BPMU.F | CHF 51.26 | 0% | n/a | CHF 571.5m | CHF 79.58 | PS3.8x | E34.4% | 0% | Pharmaceuticals & Biotech | ||
ALDX | US$5.37 | -11.1% | -14.2% | US$320.9m | US$10.00 | PB3.2x | E62.3% | n/a | Pharmaceuticals & Biotech | ||
CAPR | US$9.99 | 100.2% | 71.8% | US$365.4m | US$31.00 | PS13x | E68.7% | n/a | Pharmaceuticals & Biotech | ||
IVBI.Y | HK$22.00 | 0% | n/a | HK$73.1b | HK$28.79 | PS8.8x | E59.4% | n/a | Pharmaceuticals & Biotech |